弱視禁制療法的經驗談

Experience with Penalization in the Treatment of Amblyopia

林隆光(Luke Long-Kuang Lin)

《中華民國眼科醫學會會刊》 20卷 (1981/05) Pp. 200-204

https://doi.org/10.30048/ACTASOS.198105.0039

摘要

本文選擇56位（男35，女21）年齡從4歲到14歲，患有斜視性(33)或不等視性(23)弱視的病童。給予健眼點阿托品，每天一至二次，施行禁制療法。有46名連續點眼治療半年以上，最長達15個月。結果弱視眼視力進步視標兩行或以上的分別為78%（斜視性弱視）及95%（不等視性弱視）。而視力達到0.9或以上者分別有41%及68%，平均52%。無法接受禁制療法的原因包括局部過敏和點葯後的不舒服。

並列摘要

Totally 56 patients with strabismic or anisometropic amblyopia were given 1% Atropine eyedrop once or twice a day, after correction for refraction errors. Of them, we dropped out 10 because of hypersensitivity to atropine (3 cases) and intolerance to drug effects (7 cases). The enrolled 46 children were treated for an average of ten months (from 6 to 15 months). Visual acuity improved two lines or more in 21 eyes of 27 strabismic amblyopia and 18 eyes of 19 anisometropes. Finally 52% of all patients with penalization reached 0.9 or better in their amblyopic eyes.